Monitoring of Donor Chimerism in CD34+ Peripheral Blood Progenitors Allows to Detect Minimal Residual Disease after Allogeneic Stem Cell Transplantation -Results of a Randomized TrialMartin Bornhaeuser, Christian Thiede, Gesine Bug et al.|Blood|2008Cited by 1